Ginwa Enterprise Group Inc
医疗健康 · 专科与仿制药
Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also involved in the pharmaceutical logistics activities. The company was founded in 1996 and is headquartered in Xi'an, China.
MARKET 市值 1.78B CNY PE 95.4x
Fwd 60.6x 52W ¥4.26 – ¥9.35
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY 18.3%
▲ ROE 1.1% 营业利润率 8.1% 净利润率 3.2%